Total Funding
47
69
Total FundingVenture - Series Unknown raised
Growth Score 47 in past quarter
-5 pts
Heat Score 69 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
46934
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.
Acquired by 
EMV Capital
- Robert Englert: CEO & Board Member
- Elodie Sollier: Co-Founder & CSO
About the Company
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly from
whole blood.
Women Founded